Form 4: Inari Medical's Chief Medical Officer, Thomas Tu, Reports Stock Sale

Thomas Tu, Chief Medical Officer of Inari Medical, Inc., reported the sale of 3,480 shares of common stock on July 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On July 16, 2024, Thomas Tu, the Chief Medical Officer of Inari Medical, Inc., sold 3,480 shares of the company's common stock.
• The sale was executed at a weighted average price of $55.16 per share, with individual trades ranging from $55.00 to $55.52.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 11, 2023.
• Following the reported transaction, Thomas Tu still beneficially owns 309,777 shares of Inari Medical, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company insiders are a common occurrence and are often related to personal financial planning rather than a reflection of the company's performance. Rule 10b5-1 plans are designed to allow insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased selling pressure, but the effect is likely minimal given the relatively small volume of shares sold.

Key Dates